SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,542.44 43.27
( 0.06%)

Global Indices

Nasdaq

54,056.75 150.65
(0.28%)

Dow Jones

7,778.11 47.15
(0.61%)

Hang Seng

66,870.65 1,263.94
(1.93%)

Nikkei 225

10,869.98 -31.11
(-0.29%)

Forex

USD-INR

95.20 0.13
(0.14%)

EUR-INR

109.83 0.08
(0.08%)

GBP-INR

128.13 0.14
(0.11%)

JPY-INR

0.60 0.00
(-0.12%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Natco Pharma Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524816

INE987B01026

477.507017

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

NATCOPHARM

12.82

16427.06

EPS(TTM)

Face Value()

Div & Yield %

71.55

0.54

Back

Nucleus Software Exports consolidated net profit declines 40.81% in the December 2025 quarter

Feb 10,2026

Net profit of Nucleus Software Exports declined 40.81% to Rs 20.70 crore in the quarter ended December 2025 as against Rs 34.97 crore during the previous quarter ended December 2024. Sales rose 6.97% to Rs 220.03 crore in the quarter ended December 2025 as against Rs 205.70 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	220.03	205.70	7
OPM %	15.10	16.14	-
PBDT	47.84	48.58	-2
PBT	43.51	45.00	-3
NP	20.70	34.97	-41

78,542.44 43.27 ( 0.06%)

54,056.75 150.65 (0.28%)

7,778.11 47.15 (0.61%)

66,870.65 1,263.94 (1.93%)

10,869.98 -31.11 (-0.29%)

95.20 0.13 (0.14%)

109.83 0.08 (0.08%)

128.13 0.14 (0.11%)

0.60 0.00 (-0.12%)